[MicroRNA-s and their role in malignant hematologic diseases]

Orv Hetil. 2012 Dec 30;153(52):2051-9. doi: 10.1556/OH.2012.29511.
[Article in Hungarian]

Abstract

MicroRNAs are a class of small non-coding RNAs regulating gene expression at posttranscriptional level. Their target genes include numerous regulators of cell cycle, cell proliferation as well as apoptosis. Therefore, they are implicated in the initiation and progression of cancer, tissue invasion and metastasis formation as well. MicroRNA profiles supply much information about both the origin and the differentiation state of tumours. MicroRNAs also have a key role during haemopoiesis. An altered expression level of those have often been observed in different types of leukemia. There are successful attempts to apply microRNAs in the diagnosis and prognosis of acute lymphoblastic leukemia and acute myeloid leukemia. Measurement of the expression levels may help to predict the success of treatment with different kinds of chemotherapeutic drugs. MicroRNAs are also regarded as promising therapeutic targets, and can contribute to a more personalized therapeutic approach in haemato-oncologic patients.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Apoptosis / genetics
  • Cell Cycle Proteins / genetics
  • Cell Proliferation
  • Disease Progression
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Hematologic Neoplasms / diagnosis*
  • Hematologic Neoplasms / drug therapy
  • Hematologic Neoplasms / genetics*
  • Hematologic Neoplasms / pathology
  • Humans
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / genetics
  • MicroRNAs / metabolism*
  • Molecular Targeted Therapy
  • Neoplasm Invasiveness
  • Precision Medicine
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Prognosis

Substances

  • Cell Cycle Proteins
  • MicroRNAs